| Literature DB >> 20472033 |
Krystle L Mohawk1, Angela R Melton-Celsa, Cory M Robinson, Alison D O'Brien.
Abstract
Previously, we showed that the Shiga toxin type 2 (Stx2)-expressing Escherichia coli O157:H7 strain 86-24 colonized mice better than did its isogenic stx(2) negative mutant. Here, we confirmed that finding by demonstrating that Stx2 given orally to mice increased the levels of the 86-24 stx(2) mutant shed in feces. Then we assessed the impact of Stx2-neutralizing antibodies, administered passively or generated by immunization with an Stx2 toxoid, on E. coli O157:H7 colonization of mice. We found that such antibodies reduced the E. coli O157:H7 burden in infected mice and, as anticipated, also protected them from weight loss and death. Published by Elsevier Ltd.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20472033 PMCID: PMC2897901 DOI: 10.1016/j.vaccine.2010.04.099
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641